Global Prostate Cancer Treatment Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

November 2018 | 117 pages | ID: G4CD3F0B224EN
GlobalInfoResearch

Abstracts

Prostate cancer is the most common cancer among men, the key risk factors for prostate cancer development is being old age, genetic, obesity and race.

Scope of the Report:

The worldwide market for Prostate Cancer Treatment Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the Prostate Cancer Treatment Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

• Tolmar
• Astellas Pharma
• AstraZeneca
• Ferring Pharmaceuticals
• Johnson & Johnson
• Abbott
• Sanofi
• Ipsen
• Novartis
• Bayer

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Enzalutamid
• Abiraterone
• Leuprolide
• Goserelin
• Triptorelin
• Histrelin
• Degarelix
• Sipuleucel-T
• Docetaxel
• Cabazitaxel

Market Segment by Applications, can be divided into

• Hospital
• Research Institution
• Clinic
• Drugstore

There are 15 Chapters to deeply display the global Prostate Cancer Treatment Drugs market.

Chapter 1, to describe Prostate Cancer Treatment Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Prostate Cancer Treatment Drugs, with sales, revenue, and price of Prostate Cancer Treatment Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Prostate Cancer Treatment Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Prostate Cancer Treatment Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Prostate Cancer Treatment Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Prostate Cancer Treatment Drugs Introduction
1.2 Market Analysis by Type
  1.2.1 Enzalutamid
  1.2.2 Abiraterone
  1.2.3 Leuprolide
  1.2.4 Goserelin
  1.2.5 Triptorelin
  1.2.6 Histrelin
  1.2.7 Degarelix
  1.2.8 Sipuleucel-T
  1.2.9 Docetaxel
  1.2.10 Cabazitaxel
1.3 Market Analysis by Applications
  1.3.1 Hospital
  1.3.2 Research Institution
  1.3.3 Clinic
  1.3.4 Drugstore
1.4 Market Analysis by Regions
  1.4.1 North America (United States, Canada and Mexico)
    1.4.1.1 United States Market States and Outlook (2013-2023)
    1.4.1.2 Canada Market States and Outlook (2013-2023)
    1.4.1.3 Mexico Market States and Outlook (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2013-2023)
    1.4.2.2 France Market States and Outlook (2013-2023)
    1.4.2.3 UK Market States and Outlook (2013-2023)
    1.4.2.4 Russia Market States and Outlook (2013-2023)
    1.4.2.5 Italy Market States and Outlook (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2013-2023)
    1.4.3.2 Japan Market States and Outlook (2013-2023)
    1.4.3.3 Korea Market States and Outlook (2013-2023)
    1.4.3.4 India Market States and Outlook (2013-2023)
    1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2013-2023)
    1.4.4.2 Egypt Market States and Outlook (2013-2023)
    1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    1.4.4.4 South Africa Market States and Outlook (2013-2023)
    1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Tolmar
  2.1.1 Business Overview
  2.1.2 Prostate Cancer Treatment Drugs Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Tolmar Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Astellas Pharma
  2.2.1 Business Overview
  2.2.2 Prostate Cancer Treatment Drugs Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Astellas Pharma Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 AstraZeneca
  2.3.1 Business Overview
  2.3.2 Prostate Cancer Treatment Drugs Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 AstraZeneca Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Ferring Pharmaceuticals
  2.4.1 Business Overview
  2.4.2 Prostate Cancer Treatment Drugs Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Ferring Pharmaceuticals Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Johnson & Johnson
  2.5.1 Business Overview
  2.5.2 Prostate Cancer Treatment Drugs Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Johnson & Johnson Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Abbott
  2.6.1 Business Overview
  2.6.2 Prostate Cancer Treatment Drugs Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Abbott Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Sanofi
  2.7.1 Business Overview
  2.7.2 Prostate Cancer Treatment Drugs Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Sanofi Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Ipsen
  2.8.1 Business Overview
  2.8.2 Prostate Cancer Treatment Drugs Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Ipsen Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Novartis
  2.9.1 Business Overview
  2.9.2 Prostate Cancer Treatment Drugs Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Novartis Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Bayer
  2.10.1 Business Overview
  2.10.2 Prostate Cancer Treatment Drugs Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Bayer Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL PROSTATE CANCER TREATMENT DRUGS SALES, REVENUE, MARKET SHARE AND COMPETITION BY MANUFACTURER (2016-2017)

3.1 Global Prostate Cancer Treatment Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Prostate Cancer Treatment Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
  3.3.1 Top 3 Prostate Cancer Treatment Drugs Manufacturer Market Share in 2017
  3.3.2 Top 6 Prostate Cancer Treatment Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend

4 GLOBAL PROSTATE CANCER TREATMENT DRUGS MARKET ANALYSIS BY REGIONS

4.1 Global Prostate Cancer Treatment Drugs Sales, Revenue and Market Share by Regions
  4.1.1 Global Prostate Cancer Treatment Drugs Sales and Market Share by Regions (2013-2018)
  4.1.2 Global Prostate Cancer Treatment Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
4.5 South America Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

5 NORTH AMERICA PROSTATE CANCER TREATMENT DRUGS BY COUNTRIES

5.1 North America Prostate Cancer Treatment Drugs Sales, Revenue and Market Share by Countries
  5.1.1 North America Prostate Cancer Treatment Drugs Sales and Market Share by Countries (2013-2018)
  5.1.2 North America Prostate Cancer Treatment Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

6 EUROPE PROSTATE CANCER TREATMENT DRUGS BY COUNTRIES

6.1 Europe Prostate Cancer Treatment Drugs Sales, Revenue and Market Share by Countries
  6.1.1 Europe Prostate Cancer Treatment Drugs Sales and Market Share by Countries (2013-2018)
  6.1.2 Europe Prostate Cancer Treatment Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
6.3 UK Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
6.4 France Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

7 ASIA-PACIFIC PROSTATE CANCER TREATMENT DRUGS BY COUNTRIES

7.1 Asia-Pacific Prostate Cancer Treatment Drugs Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Prostate Cancer Treatment Drugs Sales and Market Share by Countries (2013-2018)
  7.1.2 Asia-Pacific Prostate Cancer Treatment Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
7.5 India Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

8 SOUTH AMERICA PROSTATE CANCER TREATMENT DRUGS BY COUNTRIES

8.1 South America Prostate Cancer Treatment Drugs Sales, Revenue and Market Share by Countries
  8.1.1 South America Prostate Cancer Treatment Drugs Sales and Market Share by Countries (2013-2018)
  8.1.2 South America Prostate Cancer Treatment Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA PROSTATE CANCER TREATMENT DRUGS BY COUNTRIES

9.1 Middle East and Africa Prostate Cancer Treatment Drugs Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Prostate Cancer Treatment Drugs Sales and Market Share by Countries (2013-2018)
  9.1.2 Middle East and Africa Prostate Cancer Treatment Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

10 GLOBAL PROSTATE CANCER TREATMENT DRUGS MARKET SEGMENT BY TYPE

10.1 Global Prostate Cancer Treatment Drugs Sales, Revenue and Market Share by Type (2013-2018)
  10.1.1 Global Prostate Cancer Treatment Drugs Sales and Market Share by Type (2013-2018)
  10.1.2 Global Prostate Cancer Treatment Drugs Revenue and Market Share by Type (2013-2018)
10.2 Enzalutamid Sales Growth and Price
  10.2.1 Global Enzalutamid Sales Growth (2013-2018)
  10.2.2 Global Enzalutamid Price (2013-2018)
10.3 Abiraterone Sales Growth and Price
  10.3.1 Global Abiraterone Sales Growth (2013-2018)
  10.3.2 Global Abiraterone Price (2013-2018)
10.4 Leuprolide Sales Growth and Price
  10.4.1 Global Leuprolide Sales Growth (2013-2018)
  10.4.2 Global Leuprolide Price (2013-2018)
10.5 Goserelin Sales Growth and Price
  10.5.1 Global Goserelin Sales Growth (2013-2018)
  10.5.2 Global Goserelin Price (2013-2018)
10.6 Triptorelin Sales Growth and Price
  10.6.1 Global Triptorelin Sales Growth (2013-2018)
  10.6.2 Global Triptorelin Price (2013-2018)
10.7 Histrelin Sales Growth and Price
  10.7.1 Global Histrelin Sales Growth (2013-2018)
  10.7.2 Global Histrelin Price (2013-2018)
10.8 Degarelix Sales Growth and Price
  10.8.1 Global Degarelix Sales Growth (2013-2018)
  10.8.2 Global Degarelix Price (2013-2018)
10.9 Sipuleucel-T Sales Growth and Price
  10.9.1 Global Sipuleucel-T Sales Growth (2013-2018)
  10.9.2 Global Sipuleucel-T Price (2013-2018)
10.10 Docetaxel Sales Growth and Price
  10.10.1 Global Docetaxel Sales Growth (2013-2018)
  10.10.2 Global Docetaxel Price (2013-2018)
10.11 Cabazitaxel Sales Growth and Price
  10.11.1 Global Cabazitaxel Sales Growth (2013-2018)
  10.11.2 Global Cabazitaxel Price (2013-2018)

11 GLOBAL PROSTATE CANCER TREATMENT DRUGS MARKET SEGMENT BY APPLICATION

11.1 Global Prostate Cancer Treatment Drugs Sales Market Share by Application (2013-2018)
11.2 Hospital Sales Growth (2013-2018)
11.3 Research Institution Sales Growth (2013-2018)
11.4 Clinic Sales Growth (2013-2018)
11.5 Drugstore Sales Growth (2013-2018)

12 PROSTATE CANCER TREATMENT DRUGS MARKET FORECAST (2018-2023)

12.1 Global Prostate Cancer Treatment Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Prostate Cancer Treatment Drugs Market Forecast by Regions (2018-2023)
  12.2.1 North America Prostate Cancer Treatment Drugs Market Forecast (2018-2023)
  12.2.2 Europe Prostate Cancer Treatment Drugs Market Forecast (2018-2023)
  12.2.3 Asia-Pacific Prostate Cancer Treatment Drugs Market Forecast (2018-2023)
  12.2.4 South America Prostate Cancer Treatment Drugs Market Forecast (2018-2023)
  12.2.5 Middle East and Africa Prostate Cancer Treatment Drugs Market Forecast (2018-2023)
12.3 Prostate Cancer Treatment Drugs Market Forecast by Type (2018-2023)
  12.3.1 Global Prostate Cancer Treatment Drugs Sales Forecast by Type (2018-2023)
  12.3.2 Global Prostate Cancer Treatment Drugs Market Share Forecast by Type (2018-2023)
12.4 Prostate Cancer Treatment Drugs Market Forecast by Application (2018-2023)
  12.4.1 Global Prostate Cancer Treatment Drugs Sales Forecast by Application (2018-2023)
  12.4.2 Global Prostate Cancer Treatment Drugs Market Share Forecast by Application (2018-2023)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Prostate Cancer Treatment Drugs Picture
Table Product Specifications of Prostate Cancer Treatment Drugs
Figure Global Sales Market Share of Prostate Cancer Treatment Drugs by Types in 2017
Table Prostate Cancer Treatment Drugs Types for Major Manufacturers
Figure Enzalutamid Picture
Figure Abiraterone Picture
Figure Leuprolide Picture
Figure Goserelin Picture
Figure Triptorelin Picture
Figure Histrelin Picture
Figure Degarelix Picture
Figure Sipuleucel-T Picture
Figure Docetaxel Picture
Figure Cabazitaxel Picture
Figure Prostate Cancer Treatment Drugs Sales Market Share by Applications in 2017
Figure Hospital Picture
Figure Research Institution Picture
Figure Clinic Picture
Figure Drugstore Picture
Figure United States Prostate Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Prostate Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Prostate Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Prostate Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure France Prostate Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure UK Prostate Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Prostate Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Prostate Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure China Prostate Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Prostate Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Prostate Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure India Prostate Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Prostate Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Prostate Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Prostate Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Prostate Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Prostate Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Prostate Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Table Tolmar Basic Information, Manufacturing Base and Competitors
Table Tolmar Prostate Cancer Treatment Drugs Type and Applications
Table Tolmar Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table Astellas Pharma Prostate Cancer Treatment Drugs Type and Applications
Table Astellas Pharma Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Prostate Cancer Treatment Drugs Type and Applications
Table AstraZeneca Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ferring Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Ferring Pharmaceuticals Prostate Cancer Treatment Drugs Type and Applications
Table Ferring Pharmaceuticals Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Prostate Cancer Treatment Drugs Type and Applications
Table Johnson & Johnson Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Prostate Cancer Treatment Drugs Type and Applications
Table Abbott Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Prostate Cancer Treatment Drugs Type and Applications
Table Sanofi Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ipsen Basic Information, Manufacturing Base and Competitors
Table Ipsen Prostate Cancer Treatment Drugs Type and Applications
Table Ipsen Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Prostate Cancer Treatment Drugs Type and Applications
Table Novartis Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Prostate Cancer Treatment Drugs Type and Applications
Table Bayer Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Prostate Cancer Treatment Drugs Sales by Manufacturer (2016-2017)
Figure Global Prostate Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016
Figure Global Prostate Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017
Table Global Prostate Cancer Treatment Drugs Revenue by Manufacturer (2016-2017)
Figure Global Prostate Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016
Figure Global Prostate Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2017
Figure Top 3 Prostate Cancer Treatment Drugs Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Prostate Cancer Treatment Drugs Manufacturer (Revenue) Market Share in 2017
Figure Global Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Global Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Table Global Prostate Cancer Treatment Drugs Sales by Regions (2013-2018)
Table Global Prostate Cancer Treatment Drugs Sales Market Share by Regions (2013-2018)
Table Global Prostate Cancer Treatment Drugs Revenue by Regions (2013-2018)
Figure Global Prostate Cancer Treatment Drugs Revenue Market Share by Regions in 2013
Figure Global Prostate Cancer Treatment Drugs Revenue Market Share by Regions in 2017
Figure North America Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Europe Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure South America Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure North America Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Table North America Prostate Cancer Treatment Drugs Sales by Countries (2013-2018)
Table North America Prostate Cancer Treatment Drugs Sales Market Share by Countries (2013-2018)
Figure North America Prostate Cancer Treatment Drugs Sales Market Share by Countries in 2013
Figure North America Prostate Cancer Treatment Drugs Sales Market Share by Countries in 2017
Table North America Prostate Cancer Treatment Drugs Revenue by Countries (2013-2018)
Table North America Prostate Cancer Treatment Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Prostate Cancer Treatment Drugs Revenue Market Share by Countries in 2013
Figure North America Prostate Cancer Treatment Drugs Revenue Market Share by Countries in 2017
Figure United States Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Canada Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Mexico Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Europe Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Table Europe Prostate Cancer Treatment Drugs Sales by Countries (2013-2018)
Table Europe Prostate Cancer Treatment Drugs Sales Market Share by Countries (2013-2018)
Table Europe Prostate Cancer Treatment Drugs Revenue by Countries (2013-2018)
Figure Europe Prostate Cancer Treatment Drugs Revenue Market Share by Countries in 2016
Figure Europe Prostate Cancer Treatment Drugs Revenue Market Share by Countries in 2017
Figure Germany Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure UK Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure France Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Russia Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Italy Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Prostate Cancer Treatment Drugs Sales by Countries (2013-2018)
Table Asia-Pacific Prostate Cancer Treatment Drugs Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Prostate Cancer Treatment Drugs Sales Market Share by Countries 2017
Table Asia-Pacific Prostate Cancer Treatment Drugs Revenue by Countries (2013-2018)
Figure Asia-Pacific Prostate Cancer Treatment Drugs Revenue Market Share by Countries 2017
Figure China Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Japan Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Korea Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure India Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Southeast Asia Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure South America Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Table South America Prostate Cancer Treatment Drugs Sales by Countries (2013-2018)
Table South America Prostate Cancer Treatment Drugs Sales Market Share by Countries (2013-2018)
Figure South America Prostate Cancer Treatment Drugs Sales Market Share by Countries in 2017
Table South America Prostate Cancer Treatment Drugs Revenue by Countries (2013-2018)
Table South America Prostate Cancer Treatment Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Prostate Cancer Treatment Drugs Revenue Market Share by Countries in 2017
Figure Brazil Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Argentina Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Colombia Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Prostate Cancer Treatment Drugs Sales by Countries (2013-2018)
Table Middle East and Africa Prostate Cancer Treatment Drugs Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Prostate Cancer Treatment Drugs Sales Market Share by Countries in 2017
Table Middle East and Africa Prostate Cancer Treatment Drugs Revenue by Countries (2013-2018)
Table Middle East and Africa Prostate Cancer Treatment Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Prostate Cancer Treatment Drugs Revenue Market Share by Countries in 2013
Figure Middle East and Africa Prostate Cancer Treatment Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure UAE Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Egypt Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Nigeria Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure South Africa Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Table Global Prostate Cancer Treatment Drugs Sales by Type (2013-2018)
Table Global Prostate Cancer Treatment Drugs Sales Share by Type (2013-2018)
Table Global Prostate Cancer Treatment Drugs Revenue by Type (2013-2018)
Table Global Prostate Cancer Treatment Drugs Revenue Share by Type (2013-2018)
Figure Global Enzalutamid Sales Growth (2013-2018)
Figure Global Enzalutamid Price (2013-2018)
Figure Global Abiraterone Sales Growth (2013-2018)
Figure Global Abiraterone Price (2013-2018)
Figure Global Leuprolide Sales Growth (2013-2018)
Figure Global Leuprolide Price (2013-2018)
Figure Global Goserelin Sales Growth (2013-2018)
Figure Global Goserelin Price (2013-2018)
Figure Global Triptorelin Sales Growth (2013-2018)
Figure Global Triptorelin Price (2013-2018)
Figure Global Histrelin Sales Growth (2013-2018)
Figure Global Histrelin Price (2013-2018)
Figure Global Degarelix Sales Growth (2013-2018)
Figure Global Degarelix Price (2013-2018)
Figure Global Sipuleucel-T Sales Growth (2013-2018)
Figure Global Sipuleucel-T Price (2013-2018)
Figure Global Docetaxel Sales Growth (2013-2018)
Figure Global Docetaxel Price (2013-2018)
Figure Global Cabazitaxel Sales Growth (2013-2018)
Figure Global Cabazitaxel Price (2013-2018)
Table Global Prostate Cancer Treatment Drugs Sales by Application (2013-2018)
Table Global Prostate Cancer Treatment Drugs Sales Share by Application (2013-2018)
Figure Global Research Institution Sales Growth (2013-2018)
Figure Global Clinic Sales Growth (2013-2018)
Figure Global Drugstore Sales Growth (2013-2018)
Figure Global Prostate Cancer Treatment Drugs Sales, Revenue and Growth Rate (2018-2023)
Table Global Prostate Cancer Treatment Drugs Sales Forecast by Regions (2018-2023)
Table Global Prostate Cancer Treatment Drugs Market Share Forecast by Regions (2018-2023)
Figure North America Sales Prostate Cancer Treatment Drugs Market Forecast (2018-2023)
Figure Europe Sales Prostate Cancer Treatment Drugs Market Forecast (2018-2023)
Figure Asia-Pacific Sales Prostate Cancer Treatment Drugs Market Forecast (2018-2023)
Figure South America Sales Prostate Cancer Treatment Drugs Market Forecast (2018-2023)
Figure Middle East and Africa Sales Prostate Cancer Treatment Drugs Market Forecast (2018-2023)
Table Global Prostate Cancer Treatment Drugs Sales Forecast by Type (2018-2023)
Table Global Prostate Cancer Treatment Drugs Market Share Forecast by Type (2018-2023)
Table Global Prostate Cancer Treatment Drugs Sales Forecast by Application (2018-2023)
Table Global Prostate Cancer Treatment Drugs Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List